11.5 Uses of radioisotopes  (Page 35/7)

Radioactive isotopes have the same chemical properties as stable isotopes of the same element, but they emit radiation, which can be detected. If we replace one (or more) atom(s) with radioisotope(s) in a compound, we can track them by monitoring their radioactive emissions. This type of compound is called a radioactive tracer    (or radioactive label ). Radioisotopes are used to follow the paths of biochemical reactions or to determine how a substance is distributed within an organism. Radioactive tracers are also used in many medical applications, including both diagnosis and treatment. They are used to measure engine wear, analyze the geological formation around oil wells, and much more.

Radioisotopes have revolutionized medical practice (see Appendix M ), where they are used extensively. Over 10 million nuclear medicine procedures and more than 100 million nuclear medicine tests are performed annually in the United States. Four typical examples of radioactive tracers used in medicine are technetium-99 $({}_{43}^{99}\text{Tc})$ , thallium-201 $({}_{81}^{201}\text{Tl})$ , iodine-131 $({}_{53}^{131}\text{I})$ , and sodium-24 $({}_{11}^{24}\text{Na})$ . Damaged tissues in the heart, liver, and lungs absorb certain compounds of technetium-99 preferentially. After it is injected, the location of the technetium compound, and hence the damaged tissue, can be determined by detecting the γ rays emitted by the Tc-99 isotope. Thallium-201 ( [link] ) becomes concentrated in healthy heart tissue, so the two isotopes, Tc-99 and Tl-201, are used together to study heart tissue. Iodine-131 concentrates in the thyroid gland, the liver, and some parts of the brain. It can therefore be used to monitor goiter and treat thyroid conditions, such as Grave’s disease, as well as liver and brain tumors. Salt solutions containing compounds of sodium-24 are injected into the bloodstream to help locate obstructions to the flow of blood.

Radioisotopes used in medicine typically have short half-lives—for example, the ubiquitous Tc-99m has a half-life of 6.01 hours. This makes Tc-99m essentially impossible to store and prohibitively expensive to transport, so it is made on-site instead. Hospitals and other medical facilities use Mo-99 (which is primarily extracted from U-235 fission products) to generate Tc-99. Mo-99 undergoes β decay with a half-life of 66 hours, and the Tc-99 is then chemically extracted ( [link] ). The parent nuclide Mo-99 is part of a molybdate ion, ${\text{MoO}}_4{}^{\mathrm{2-}};$ when it decays, it forms the pertechnetate ion, ${\text{TcO}}_4{}^{\text{−}}.$ These two water-soluble ions are separated by column chromatography, with the higher charge molybdate ion adsorbing onto the alumina in the column, and the lower charge pertechnetate ion passing through the column in the solution. A few micrograms of Mo-99 can produce enough Tc-99 to perform as many as 10,000 tests.